211 related articles for article (PubMed ID: 17202261)
1. Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins.
Ng KP; Potikyan G; Savene RO; Denny CT; Uversky VN; Lee KA
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):479-84. PubMed ID: 17202261
[TBL] [Abstract][Full Text] [Related]
2. A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the EWS/ATF1 oncogene.
Feng L; Lee KA
Oncogene; 2001 Jul; 20(31):4161-8. PubMed ID: 11464282
[TBL] [Abstract][Full Text] [Related]
3. Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis.
Showpnil IA; Miller KR; Taslim C; Pishas KI; Lessnick SL; Theisen ER
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658189
[TBL] [Abstract][Full Text] [Related]
4. Disordered binding regions of Ewing's sarcoma fusion proteins.
Todorova R
Bioorg Khim; 2014; 40(1):20-30. PubMed ID: 25898720
[TBL] [Abstract][Full Text] [Related]
5. Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing's sarcoma in vitro.
Jully B; Vijayalakshmi R; Gopal G; Sabitha K; Rajkumar T
BMC Cancer; 2012 Nov; 12():513. PubMed ID: 23145994
[TBL] [Abstract][Full Text] [Related]
6. Molecular recognition by the EWS transcriptional activation domain.
Lee KA
Adv Exp Med Biol; 2012; 725():106-25. PubMed ID: 22399321
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of the EWS oncogene transcriptional activation domain.
Ng KP; Li KK; Lee KA
Biochemistry; 2009 Apr; 48(13):2849-57. PubMed ID: 19290668
[TBL] [Abstract][Full Text] [Related]
8. A transcription assay for EWS oncoproteins in Xenopus oocytes.
Ng KP; Cheung F; Lee KA
Protein Cell; 2010 Oct; 1(10):927-34. PubMed ID: 21204019
[TBL] [Abstract][Full Text] [Related]
9. A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing's sarcoma cells, interacts with the EWS-FLI1 and partner proteins.
Thangaretnam KP; Gopisetty G; Ramanathan P; Rajkumar T
Sci Rep; 2017 Aug; 7(1):7172. PubMed ID: 28775288
[TBL] [Abstract][Full Text] [Related]
10. Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors.
Li Y; Li X; Fan G; Fukushi J; Matsumoto Y; Iwamoto Y; Zhu Y
Cancer Lett; 2012 Jul; 320(1):14-22. PubMed ID: 22266186
[TBL] [Abstract][Full Text] [Related]
11. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
12. Ewings family oncoproteins: drunk, disorderly and in search of partners.
Lee KA
Cell Res; 2007 Apr; 17(4):286-8. PubMed ID: 17426699
[No Abstract] [Full Text] [Related]
13. Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.
Kim S; Denny CT; Wisdom R
Mol Cell Biol; 2006 Apr; 26(7):2467-78. PubMed ID: 16537893
[TBL] [Abstract][Full Text] [Related]
14. Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue.
Gierisch ME; Pfistner F; Lopez-Garcia LA; Harder L; Schäfer BW; Niggli FK
J Biol Chem; 2016 Dec; 291(52):26922-26933. PubMed ID: 27875302
[TBL] [Abstract][Full Text] [Related]
15. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
[TBL] [Abstract][Full Text] [Related]
16. Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.
Niedan S; Kauer M; Aryee DN; Kofler R; Schwentner R; Meier A; Pötschger U; Kontny U; Kovar H
Oncogene; 2014 Jul; 33(30):3927-38. PubMed ID: 23995784
[TBL] [Abstract][Full Text] [Related]
17. Structure-function based molecular relationships in Ewing's sarcoma.
Todorova R
Biomed Res Int; 2015; 2015():798426. PubMed ID: 25688366
[TBL] [Abstract][Full Text] [Related]
18. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF
Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944
[TBL] [Abstract][Full Text] [Related]
19. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
20. RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains.
Alex D; Lee KA
Nucleic Acids Res; 2005; 33(4):1323-31. PubMed ID: 15743974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
